Conor F. Larkin

Partner

Philadelphia Phone +1.215.963.5343 Fax +1.215.963.5001

1701 Market St.//Philadelphia, PA 19103-2921//United States

Conor F. Larkin advises clients on a variety of corporate matters, with an emphasis on advising public and private companies, including private equity firms, on domestic and cross-border mergers and acquisitions, joint ventures, and financing transactions. Conor also draws on his background as an investor relations consultant to counsel public company clients on securities and corporate governance matters, including environmental, social and governance (ESG) strategy and communications. His oil and gas work includes representation of master limited partnerships and negotiating long-term storage, terminalling and throughput agreements. His life sciences work includes structuring and negotiating royalty monetization transactions on behalf of investors and royalty holders.

Before attending law school, Conor worked in the corporate advisory division of Thomson Reuters in New York, where he counseled Fortune 500 companies on their investor relations efforts and best practices for investor relations and financial communications.

selected representations

Significant transactional representations (in addition to general day-to-day corporate and securities compliance representations) include:

Life Sciences and Royalty Monetization Transactions

Integra LifeSciences Holdings Corporation in the sale of its Extremity Orthopedics business to Smith+Nephew
Healthcare Royalty Partners in numerous royalty monetization transactions, including acquisitions of royalty and revenue interests from inventors, universities and companies including Infinity Pharmaceuticals, Inc., Acorda Therapeutics, Inc., Albireo Pharma, Inc. and REGENXBIO Inc.
Nevakar Inc. in royalty monetization transactions with NovaQuest Capital Management and H.I.G. Capital
Representation of a clinical stage biotechnology company in a royalty monetization transaction
Formula Pharmaceuticals in its merger with CoImmune

Energy Transactions

HollyFrontier Corp. in the $655 million acquisition of Sonneborn US Holdings Inc. and Sonneborn Coöperatief U.A., producers of high purity specialty products as one of the world’s largest dedicated suppliers of white oils, petrolatums and waxes.
MPLX Delaware Basin NGL LLC, a subsidiary of MPLX LP (MPLX) and Marathon Petroleum Corp. (MPC), in a joint venture with WhiteWater Midstream LLC to acquire a 30% interest in a 323-mile natural gas liquids pipeline in Texas from EPIC Midstream LLC
Buckeye Partners, L.P. in the formation of a joint venture with Phillips 66 Partners LP and Andeavor to develop a new $300 million deep-water, open access marine terminal in Ingleside, Texas.
HollFrontier Corp. in its $1.25 billion IDR elimination transaction with Holly Energy Partners, including the acquisition of common units of Holly Energy Partners.
HollyFrontier Corp. in its $845 million acquisition of Suncor Energy’s Petro-Canada lubricants business.
Representation of a refined products MLP in connection with its $860 million acquisition of condensate splitters and a high-volume marine crude terminal in South Texas and crude gathering facilities in the Eagle Ford shale play, including the negotiation of numerous long-term tolling, storage, throughput and dock services agreements.
Representation of a terminalling and storage company in its $850 million acquisition of 20 liquids storage marine terminals, including the negotiation of long-term storage and throughput agreements.
Representation of master limited partnership in its acquisition of a propane distribution business.